Pharma success increasingly depends on proving value

05/15/2013 | PharmaTimes (U.K.)

A drug's success in the marketplace increasingly depends on the drugmaker's ability to prove value and additional benefit over existing pharmaceuticals, yet many drugmakers still take a blockbuster approach to development, an international survey by Camelot Management Consultants finds. Germany and the U.K. are among the nations linking reimbursement price to additional benefit, which drives pricing elsewhere.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY